Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats

European Journal of Pharmacology

Volumn 549, Issue 1-3, 2006, Pages 98-106

  Li, Yuxin ^a   Fukuda, Noboru ^a,b   Yokoyama, Shin Ichiro ^a   Kusumi, Yoshiaki ^a   Hagikura, Kazuhiro ^a   Kawano, Taro ^a   Takayama, Tadateru ^a   Matsumoto, Taro ^a   Satomi, Aya ^a   Honye, Junko ^a   Mugishima, Hideo ^a   Mitsumata, Masako ^a   Saito, Satoshi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Coronary disease; Cytokine; Infarction; Restenosis; Stem cell

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; SODIUM CHLORIDE;

ACUTE HEART INFARCTION; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY HYPERPLASIA; ARTICLE; BALLOON CATHETER; BONE MARROW CELL; BRAIN INFARCTION SIZE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; HEART; HEART LEFT VENTRICLE; HYPERPLASIA; INTIMA; LEFT CORONARY ARTERY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; TRANSGENIC ORGANISM;

ACTINS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE MARROW TRANSPLANTATION; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUNICA INTIMA; VENTRICULAR REMODELING; VON WILLEBRAND FACTOR;

EID: 33748981453     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.006     Document Type: Article

References (33)

1. Adachi Y., Imagawa J., Suzuki Y., Yogo K., Fukazawa M., Kuromaru O., and Saito Y. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J. Mol. Cell. Cardiol. 36 (2004) 707-710
2. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88 (1996) 761-777
3. Berliner N., Hsing A., Graubert T., Sigurdsson F., Zain M., Bruno E., and Hoffman R. Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 85 (1995) 799-803
4. Campbell J.H., Han C.L., and Campbell G.R. Neointimal formation by circulating bone marrow cells. Ann. N. Y. Acad. Sci. 947 (2001) 18-24 (discussion 24-15)
5. Griese D.P., Ehsan A., Melo L.G., Kong D., Zhang L., Mann M.J., Pratt R.E., Mulligan R.C., and Dzau V.J. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108 (2003) 2710-2715
6. Grimm D., Cameron D., Griese D.P., Riegger G.A., and Kromer E.P. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc. Res. 40 (1998) 297-306
7. Han C.I., Campbell G.R., and Campbell J.H. Circulating bone marrow cells can contribute to neointimal formation. J. Vasc. Res. 38 (2001) 113-119
8. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., Ohtsuka M., Matsuura K., Sano M., Nishi J., Iwanaga K., Akazawa H., Kunieda T., Zhu W., Hasegawa H., Kunisada K., Nagai T., Nakaya H., Yamauchi-Takihara K., and Komuro I. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11 (2005) 305-311
9. Hill J.M., Syed M.A., Arai A.E., Powell T.M., Paul J.D., Zalos G., Read E.J., Khuu H.M., Leitman S.F., Horne M., Csako G., Dunbar C.E., Waclawiw M.A., and Cannon III R.O. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. 46 (2005) 1643-1648
10. Hu Y., Davison F., Ludewig B., Erdel M., Mayr M., Url M., Dietrich H., and Xu Q. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 106 (2002) 1834-1839
11. Hu Y., Mayr M., Metzler B., Erdel M., Davison F., and Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ. Res. 91 (2002) e13-e20
12. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., Kim Y.J., Soo Lee D., Sohn D.W., Han K.S., Oh B.H., Lee M.M., and Park Y.B. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
13. Kawada H., Fujita J., Kinjo K., Matsuzaki Y., Tsuma M., Miyatake H., Muguruma Y., Tsuboi K., Itabashi Y., Ikeda Y., Ogawa S., Okano H., Hotta T., Ando K., and Fukuda K. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104 (2004) 3581-3587
14. Kong D., Melo L.G., Gnecchi M., Zhang L., Mostoslavsky G., Liew C.C., Pratt R.E., and Dzau V.J. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004) 2039-2046
15. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., Koda M., Arai M., Misao Y., Lu C., Suzuki K., Goto K., Komada A., Takahashi T., Kosai K., Fujiwara T., and Fujiwara H. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
16. Moon C., Krawczyk M., Ahn D., Ahmet I., Paik D., Lakatta E.G., and Talan M.I. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11612-11617
17. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., and Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
18. Nadal-Ginard B., Kajstura J., Leri A., and Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92 (2003) 139-150
19. Ohlstein E.H., Romanic A.M., Clark L.V., Kapadia R.D., Sarkar S.K., Gagnon R., and Chandra S. Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery. Cardiovasc. Res. 47 (2000) 759-768
20. Ohtsuka M., Takano H., Zou Y., Toko H., Akazawa H., Qin Y., Suzuki M., Hasegawa H., Nakaya H., and Komuro I. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 18 (2004) 851-853
21. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10344-10349
22. Pauletto P., Sartore S., and Pessina A.C. Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin. Sci. (Lond) 87 (1994) 467-479
23. Petzsch M., Ince H., Kleine H., Schmidt H., Rehders T., Korber T., Freund M., and Nienaber C. No restenosis after G-CSF in acute myocardial infarction: insights from FIRSTLINE-AMI (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor). Circulation Suppl. III 110 III-238 (2004) (abstract)
24. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44 (1979) 503-512
25. Qian J.Y., Haruno A., Asada Y., Nishida T., Saito Y., Matsuda T., and Ueno H. Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ. Res. 91 (2002) 1063-1069
26. Ripa R., Wang Y., Jorgensen E., and Kastrup J. Bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor in patients with a PCI-treated acute ST-elevation myocardial infarction is safe: results from a double-blind randomized study, the stem cells in myocardial infarction (STEMMI) trial. Circulation Suppl. III 110 III-238 (2004) (abstract)
27. Schwartz R.S. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. Am. J. Cardiol. 81 (1998) 14E-17E
28. Shoji M., Sata M., Fukuda D., Tanaka K., Sato T., Iso Y., Shibata M., Suzuki H., Koba S., Geshi E., and Katagiri T. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc. Pathol. 13 (2004) 306-312
29. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
30. Tanaka K., Sata M., Hirata Y., and Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ. Res. 93 (2003) 783-790
31. Valgimigli M., Rigolin G.M., Cittanti C., Malagutti P., Curello S., Percoco G., Bugli A.M., Della Porta M., Bragotti L.Z., Ansani L., Mauro E., Lanfranchi A., Giganti M., Feggi L., Castoldi G., and Ferrari R. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur. Heart J. 26 (2005) 1838-1845
32. Wagers A.J., Sherwood R.I., Christensen J.L., and Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297 (2002) 2256-2259
33. Zou Y., Takano H., Mizukami M., Akazawa H., Qin Y., Toko H., Sakamoto M., Minamino T., Nagai T., and Komuro I. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108 (2003) 748-753